ATOSSA THERAPEUTICS, INC.: 10-Q filed 2014-05-14
What ATOSSA THERAPEUTICS, INC. reported in its quarterly report filed 2014-05-14 (fiscal Q1 2014): 32 published measures, 82 facts as tagged in accession 0001144204-14-030427.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2014-05-14
- Fiscal period
- fiscal Q1 2014
- Accession
- 0001144204-14-030427 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ATOSSA THERAPEUTICS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 22,383,091 | USD | |
| At 2013-12-31 | 12,009,047 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 21,301,046 | USD | |
| At 2013-12-31 | 10,601,651 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 16,590,951 | USD | |
| At 2013-12-31 | 6,342,161 | USD | |
| At 2013-03-31 | 1,385,199 | USD | |
| At 2012-12-31 | 1,725,197 | USD | |
| At 2009-04-29 | 0 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | -2,411,531 | USD | 90 |
| 2009-04-30 to 2014-03-31 | -22,928,145 | USD | 1797 |
| 2013-01-01 to 2013-03-31 | -1,941,440 | USD | 90 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | -22,928,145 | USD | |
| At 2013-12-31 | -20,516,614 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 0 | USD | 90 |
| 2009-04-30 to 2014-03-31 | 248 | USD | 1797 |
| 2013-01-01 to 2013-03-31 | 0 | USD | 90 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 129,942 | USD | |
| At 2013-12-31 | 163,147 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 230,181 | USD | 90 |
| 2009-04-30 to 2014-03-31 | 1,966,205 | USD | 1797 |
| 2013-01-01 to 2013-03-31 | 274,512 | USD | 90 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | -2,410,925 | USD | 90 |
| 2009-04-30 to 2014-03-31 | -22,894,643 | USD | 1797 |
| 2013-01-01 to 2013-03-31 | -1,941,433 | USD | 90 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 17,700,133 | USD | |
| At 2013-12-31 | 7,413,821 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 749 | USD | 90 |
| 2009-04-30 to 2014-03-31 | 40,280 | USD | 1797 |
| 2013-01-01 to 2013-03-31 | 7 | USD | 90 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 1,082,045 | USD | |
| At 2013-12-31 | 1,407,396 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 0 | USD | |
| At 2013-12-31 | 9,634 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 4,491,707 | USD | |
| At 2013-12-31 | 4,395,633 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 91,416 | USD | |
| At 2013-12-31 | 139,072 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 2,435,049 | USD | 90 |
| 2009-04-30 to 2014-03-31 | 23,376,383 | USD | 1797 |
| 2013-01-01 to 2013-03-31 | 2,057,639 | USD | 90 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 0 | USD | |
| At 2013-12-31 | 0 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 24,124 | USD | 90 |
| 2009-04-30 to 2014-03-31 | 481,740 | USD | 1797 |
| 2013-01-01 to 2013-03-31 | 116,206 | USD | 90 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 0 | USD | 90 |
| 2009-04-30 to 2014-03-31 | 386,428 | USD | 1797 |
| 2013-01-01 to 2013-03-31 | 66,464 | USD | 90 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 422,503 | USD | 90 |
| 2009-04-30 to 2014-03-31 | 5,084,999 | USD | 1797 |
| 2013-01-01 to 2013-03-31 | 220,192 | USD | 90 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 24,428,568 | shares | |
| At 2013-12-31 | 18,574,334 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 44,204,762 | USD | |
| At 2013-12-31 | 31,099,691 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 135,221 | USD | |
| At 2013-12-31 | 114,050 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 4,553,016 | USD | |
| At 2013-12-31 | 4,432,079 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | -2,411,531 | USD | 90 |
| 2009-04-30 to 2014-03-31 | -22,928,145 | USD | 1797 |
| 2013-01-01 to 2013-03-31 | -1,941,440 | USD | 90 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 1,774,708 | USD | 90 |
| 2009-04-30 to 2014-03-31 | 16,155,879 | USD | 1797 |
| 2013-01-01 to 2013-03-31 | 1,564,872 | USD | 90 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 21,171 | USD | 90 |
| 2013-01-01 to 2013-03-31 | 4,869 | USD | 90 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 125,097 | USD | 90 |
| 2009-04-30 to 2014-03-31 | 744,206 | USD | 1797 |
| 2013-01-01 to 2013-03-31 | 98,945 | USD | 90 |
Income taxes paid, net
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 0 | USD | 90 |
| 2009-04-30 to 2014-03-31 | 248 | USD | 1797 |
| 2013-01-01 to 2013-03-31 | 0 | USD | 90 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | -19,796 | USD | 90 |
| 2009-04-30 to 2014-03-31 | 474,137 | USD | 1797 |
| 2013-01-01 to 2013-03-31 | 117,675 | USD | 90 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 0 | USD | 90 |
| 2009-04-30 to 2014-03-31 | 271,856 | USD | 1797 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | -9,634 | USD | 90 |
| 2009-04-30 to 2014-03-31 | 0 | USD | 1797 |
| 2013-01-01 to 2013-03-31 | -33,626 | USD | 90 |
Inspect the source
- Entity
- ATOSSA THERAPEUTICS, INC. / CIK 0001488039
- Captured
- 2026-09-20T09:09:43.864Z
- SEC response SHA-256
1a9a7394baaf8eaa5fbb9f56ff3e675865210f784ada942417e365f62ac259f6
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001488039.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))